Key Details
Price
$13.16Annual ROE
-9.07%Beta
1.63Events Calendar
Next earnings date:
Feb 18, 2025Recent quarterly earnings:
Nov 5, 2024Recent annual earnings:
Feb 20, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Apr 16, 2003Analyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce the production scale-up to 20 tons per year to accommodate the increasing demand for NEO's high-performance silicon anode products and to initiate mass-producibility testing to prepare factory-level production.
TORONTO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is highly pleased to enter into a definitive lease agreement (the “Agreement”) on December 20, 2024, with the City of Windsor, Ontario (“Windsor”), securing 8 acres of surplus lands at Windsor Airport. This significant milestone marks a critical step toward establishing Canada's first advanced silicon anode manufacturing facility, further solidifying NEO's role in strengthening the Canadian battery value chain.
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics today provided financial guidance for fiscal year 2025 and updated its Long-Range Financial Plan.
NeoGenomics (NEO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Pairing Adaptive Biotechnologies' clonoSEQ MRD results with NeoGenomics' COMPASS and CHART assessment services empowers clinicians and patients with meaningful insights across the treatment continuum Pairing Adaptive Biotechnologies' clonoSEQ MRD results with NeoGenomics' COMPASS and CHART assessment services empowers clinicians and patients with meaningful insights across the treatment continuum
TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce the launch of an advanced high-performance silicon anode product called NBMSiDE® P-300 with breakthrough battery capacity. Alongside its core focus on electric vehicles and electronics, NEO is expanding its strategic downstream focus to the space and eVTOL industries through solid-state batteries.
NeoGenomics (NEO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TORONTO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce the joint development agreement (the “Agreement” or “JDA”) with a North American battery cell manufacturer (“JDA Partner”) effective November 30, 2024. This collaboration aims to develop and enhance the performance of silicon anode materials for specialty electric automotive and mobility applications. There are no material terms or considerations as part of this JDA.
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics' newly published study shows how ctDNA in MRD may enable earlier identification of disease recurrence for high-risk melanoma patients.
TORONTO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “C o mpan y”) (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, announces that Roberto Fia has resigned from the Company's Board of Directors effective November 29, 2024. NEO would like to thank him for his contributions to date.
FAQ
- What is the ticker symbol for NeoGenomics?
- Does NeoGenomics pay dividends?
- What sector is NeoGenomics in?
- What industry is NeoGenomics in?
- What country is NeoGenomics based in?
- When did NeoGenomics go public?
- Is NeoGenomics in the S&P 500?
- Is NeoGenomics in the NASDAQ 100?
- Is NeoGenomics in the Dow Jones?
- When was NeoGenomics's last earnings report?
- When does NeoGenomics report earnings?
- Should I buy NeoGenomics stock now?